TY - JOUR
T1 - Reduced glutathione level in the aqueous humor of patients with primary open-angle glaucoma and normal-tension glaucoma
AU - Sato, Kota
AU - Saigusa, Daisuke
AU - Kokubun, Taiki
AU - Fujioka, Amane
AU - Feng, Qiwei
AU - Saito, Ritsumi
AU - Uruno, Akira
AU - Matsukawa, Naomi
AU - Ohno-Oishi, Michiko
AU - Kunikata, Hiroshi
AU - Yokoyama, Yu
AU - Yasuda, Masayuki
AU - Himori, Noriko
AU - Omodaka, Kazuko
AU - Tsuda, Satoru
AU - Maekawa, Shigeto
AU - Yamamoto, Masayuki
AU - Nakazawa, Toru
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Glaucoma is a leading cause of blindness worldwide in older people. Profiling the aqueous humor, including the metabolites it contains, is useful to understand physiological and pathological conditions in the eye. In the current study, we used mass spectrometry (MS) to characterize the aqueous humor metabolomic profile and biological features of patients with glaucoma. Aqueous humor samples were collected during trabeculectomy surgery or cataract surgery and analyzed with global metabolomics. We included 40 patients with glaucoma (32 with POAG, 8 with NTG) and 37 control subjects in a discovery study. VIP analysis revealed five metabolites that were elevated and three metabolites that were reduced in the glaucoma patients. The identified metabolomic profile had an area under the receiver operating characteristic curve of 0.953. Among eight selected metabolites, the glutathione level was significantly decreased in association with visual field defects. Moreover, in a validation study to confirm the reproducibility of our findings, the glutathione level was reduced in NTG and POAG patients compared with a cataract control group. Our findings demonstrate that aqueous humor profiling can help to diagnose glaucoma and that various aqueous humor metabolites are correlated with clinical parameters in glaucoma patients. In addition, glutathione is clearly reduced in the aqueous humor of glaucoma patients with both IOP-dependent and IOP-independent disease subtypes. These findings indicate that antioxidant agents in the aqueous humor reflect glaucomatous optic nerve damage and that excessive oxidative stress may be involved in the pathogenesis of glaucoma.
AB - Glaucoma is a leading cause of blindness worldwide in older people. Profiling the aqueous humor, including the metabolites it contains, is useful to understand physiological and pathological conditions in the eye. In the current study, we used mass spectrometry (MS) to characterize the aqueous humor metabolomic profile and biological features of patients with glaucoma. Aqueous humor samples were collected during trabeculectomy surgery or cataract surgery and analyzed with global metabolomics. We included 40 patients with glaucoma (32 with POAG, 8 with NTG) and 37 control subjects in a discovery study. VIP analysis revealed five metabolites that were elevated and three metabolites that were reduced in the glaucoma patients. The identified metabolomic profile had an area under the receiver operating characteristic curve of 0.953. Among eight selected metabolites, the glutathione level was significantly decreased in association with visual field defects. Moreover, in a validation study to confirm the reproducibility of our findings, the glutathione level was reduced in NTG and POAG patients compared with a cataract control group. Our findings demonstrate that aqueous humor profiling can help to diagnose glaucoma and that various aqueous humor metabolites are correlated with clinical parameters in glaucoma patients. In addition, glutathione is clearly reduced in the aqueous humor of glaucoma patients with both IOP-dependent and IOP-independent disease subtypes. These findings indicate that antioxidant agents in the aqueous humor reflect glaucomatous optic nerve damage and that excessive oxidative stress may be involved in the pathogenesis of glaucoma.
UR - http://www.scopus.com/inward/record.url?scp=85178887101&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178887101&partnerID=8YFLogxK
U2 - 10.1038/s41514-023-00124-2
DO - 10.1038/s41514-023-00124-2
M3 - Article
AN - SCOPUS:85178887101
SN - 2056-3973
VL - 9
JO - npj Aging
JF - npj Aging
IS - 1
M1 - 28
ER -